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1. Introduction
Diabetes mellitus is the most frequently occurring chronic 
disease worldwide and is characterized by hyperglycaemia. 
It is known to rise speedily with over 550 million to be 
affected by 2030 (Wild et al., 2004) among all the countries 
in the world. The prevalence of the disease is also rising with 
agrowing population, aging, urbanization, physical inactivity 
and obesity, which will further worsen the situation of disease 
(Dennerstein et al., 2002). In diabetes mellitus is an outcome 
of impaired metabolism of fats, lipids, carbohydrates and 
proteins as well. It is found to be responsible for several 
organfailurelike renal failure, heart failure, and sexual 
dysfunction(Pontiroli et al., 2013). However, most of the 
patients with diabetes die due to cardiovascular diseases like 
stroke. It occurs at a stage when diabetes becomes chronic. 
Diabetes Mellitusacting an imperative role in the pathogenesis 
of sexual dysfunction among both females and males. Many 
studies have been accomplish to study sexual dysfunction in 
diabetic males, but there are lesser data available in diabetic 
females due to a number of reasons like a small sample size. 
According to a study conducted by Pontiroli et al., (Enzlin 
et al., 2003) and Enzlin et al., (Lehman and Jacobs, 2006). 
The prevalence rate for females lies between 25-71% and 
27% respectively. Moreover, large epidemiological studies 
suggested that the prevalence of sexual dysfunction ranges 
from 40-60% with higher rates found in postmenopausal 
women. There are many factors that are responsible for 
the etiology of sexual dysfunction among females such as 
neurological, psychological as well as vascular factors (Li 
et al., 2010; Buvat et al., 1985; Kim and Son, 2006; Skrha, 
2003; Orasanu and Plutzky, 2009). Although, the data 
available for neurological factors areless. Yet some neurological 
disorders like multiple sclerosis, lumbar radiculopathy etc. 
Can result in dysfunction of female genital organs (Buvat et 
al., 1985; Kim and Son, 2006; Skrha, 2003; Orasanu and 
Plutzky, 2009). The most common and the most useful 
observation is the Prevalence of diabetes in Asia people mainly 
it lowers the BMI of the diabetic people.The main reason is 
that the Asians are recorded as the most prominent race by 
the IOTF to be prone to the diabetic nature due to the high 
adiposity content.
1.1 Overview for the Sexual Dysfunction 
The occurrence of sexual dysfunction can result in 
symptoms like decreased libido, low accountability, 
decreased vaginal lubrication, orgasm dysfunction and 
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dyspareunia. Apart from this, diabetes also has a detrimental 
impact on the cardiovascular system which leads to diabetic 
macroangiopathy and diabetic microangiopathy (Doumas 
et al., 2006; Owiredu et al., 2011). Diabetic macroangiopathy 
is commonly known to cause the incidence of coronary artery 
disease and hypertension, whereas diabetic microangiopathy 
may develop several years after the onset of the disease. In 
addition to this, hypertension can further aggravate the 
complications of microangiopathy and macroangiopathy. 
Thus, there is a great need to control hypertension, which 
will further lessen the rates of sexual dysfunction (Basson 
et al., 2000). According to World Health Organization sexual 
dysfunction refers to a condition in which an individual 
is not able to participate in sexual intercourse as he/she 
would wish (American Psychiatric Association, 2013). 
It is categorized by disorder in the psycho physiological 
alterationin the sexual cycle of women (Veronelli et al., 
2009). Moreover, recently the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5)updated a recent 
definition of sexual dysfunction. It has been grouped 
into two categories: sexual dysfunction has been put 
intodyspareunia,veganism and female sexual interest or 
arousal disorder have been put into the “Genito-pelvic pain/
penetration disorder” category (Khalilzadeh et al., 2015). In 
general, female sexual dysfunction can be evaluated based 
on the score of the Female Sexual Function Index (FSFI). A 
lower score is associated with sexual impairment in diabetic 
females. Moreover, at the meta-regression, only BMI was 
found to be significantly associated with the FSFI score. 
Increase frequency of sexual dysfunction and lower FSFI 
score in diabetic women are basically interrelated to her 
body weight. Many studies have already established that the 
increased prevalence of dysfunction is commonly linked to 
obesity (Esposito et al., 2005; Martelli et al., 2012; Enzlin 
et al., 2002; Mezones-Holguin et al., 2008) and metabolic 
syndrome (Konuru et al., 2017; Pontiroli et al., 2013).
Type 2 diabetes in relationship with improperly low 
luteinizing hormone (LH) and follicle-fortifying hormone 
(FSH) concentrations. Female hormones controls about each 
part of erectile capacity, to the endothelial cells of the corpora 
cavernosm and from pelvic ganglions to smooth muscle. It 
likewise balances the planning of the erectile procedure, which 
happens as a component of sexual want, organizing penile 
erection with sex. It is as yet hazy level of testosterone is required 
for good erectile function; in any case, proof got from clinical and 
sub-atomic examinations bolsters the utilization of testosterone 
supplanting in hypogonadism patients with ED, in spite of 
the fact that the benefit– chance proportion is indeterminate 
in cutting edge age.The instruments engaged with testosterone 
lack in diabetes incorporate low levels of the sex hormone-
restricting globulin because of insulin obstruction, expanded 
aromatase action in instinctive fat tissue leading to an enlarged 
change of testosterone in estradiol, leptin opposition causing 
decreased emission of LH and testosterone, and expanded 
levels of fiery middle people, which may smother the discharge 
of gonadotropin-discharging hormone and LH. Bellastella 
et al., 72 proposed a conceivable immune system pathogenesis 
of hypogonadotropic hypogonadism in type 2 diabetic patients, 
as showed by the nearness of pituitary antibodies at high titers, 
as contrasted and age-coordinated controls.
2. Risk Factor
There are various established risk factors that are closely 
linked with the incidence and risk of diabetes mellitus and 
sexual dysfunction. Various micro vascular and macrovascular 
complications are caused majorly due to diabetes that greatly 
affects the sexual functioning by an individual. One of the 
most commonly occurring risk factor is depression as sexual 
health is associated with psychological factors. (Newman and 
Bertelson, 1986; Skrha, 2003) Thereby effecting lifestyle, 
self image and personal relationships. There is a need to treat 
depression by taking antidepressants. Besides psychological 
factors, several behavioural and environmental factors also raise 
the problem of sexual dysfunction which includes conditions 
like obesity, overweight, physical inactivity, (Muharam et al., 
2016) etc. Obese women are more likely to have more severe 
and a significant number of sexual problems (Lewis et al., 
2010).
Another major reason that potentiates the risk of sexual 
impairment is social, cultural risk factor which consists of 
financial issues, limited social relations, employment status 
and lack of exercise (Peng et al., 2005). Apart from this, there 
are other factors that contribute to the development of sexual 
dysfunction such as aging, (Bhasin et al., 2007) cardiovascular 
diseases, (Maiorino et al., 2014) Hypertension, (Park et al., 
2002) genitourinary disease (Feldhaus-Dahir, 2009) and 
many more chronic diseases (Patil et al., 2017; Kim and Son, 
2006). Diabetes mellitus itself is responsible for the high 
incidence of sexual problems. High glycaemic levels in the 
blood can result in painful sexual intercourse, commonly 
known as Dyspareunia (Duby et al., 2014). But, there is 
limited evidence available to support this. Dyspareunia may 
be induced when the hydration levels of the vaginal mucous 
membrane decrease. In addition, atherosclerotic damage and 
endothelial damage (Brown et al., 2005) may incite the lesser 
vaginal lubrication and clitoral engorgement. It is evident 
from several research studies that an imbalance of hormones 
such as androgens, estrogens and sex hormone binding 
globulin greatly affects sexual arousal (Feldhaus-Dahir, 2009). 
However, it can be improved by taking hormone replacement 
therapy, which is the only best possible treatment currently 
approved by certain organizations.
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3. Pathogenesis
Factors that play a role in the pathogenesis of sexual 
dysfunction in women includes: organic like hyperglycaemia, 
neural, vascular, neurovascular factors, psychological and 
psychosocial derangements.
• Hyperglycaemia: It has been already discussed 
that a decrease in lubrication or hydration of the 
mucus membrane of vagina lead to dyspareunia 
and other genitourinary infections. This makes the 
sexual intercourse, even more difficult to encounter 
because of the occurrence of arousal disorder.
• Neural and vascular factors: It is widely 
accepted that sexual arousal largely depends on 
the sympathetic nervous system, noradrenergic/
no cholinergic neurotransmitters (NANC), e.g. 
Vasoactive intestinal polypeptide (VIP) and nitric 
oxide (NO). These factors are responsible for the 
sexual function in diabetic females because these 
are basically involved in the relaxation of smooth 
muscles of genital tissues and thus increasing the 
blood flow, thereby regulating sexual functioning. 
Diabetes mellitus can lead to various structural 
as well as functional changes in a female genital 
organ which impairs the relaxation process of 
genital tissues (Schram et al., 2009) and ultimately 
sexual functions get disturbed. Other vascular 
abnormalities like endothelial cells dysfunction 
and atherosclerotic damage may reduce the 
engorgement of the clitoris and vaginal lubrication 
which can thereby cause painful sexual intercourse.
• Diabetic Neuropathy: Diabetic neuropathy is 
another important reason that plays a significant 
role in the pathogenesis of sexual abnormalities. 
This can impair both normal transduction of sexual 
stimuli as well as the triggered sexual response 
(Enzlin et al., 2009; Enzlin et al., 2003; Kumar 
Patnaik et al., 2017). In this, there is an imbalance 
in the normal levels of hormones like androgens, 
estrogens and sex hormone binding globulin 
(Rockliffe-Fidler and Kiemle, 2003). Furthermore, 
various endocrinological abnormalities may further 
aggravate the sexual problems in diabetic women, 
such aspoly cystic ovarian syndrome, hypothalamic-
pituitary dysfunction andthyroid disorders.
• Depression: Nearly half of the women face sexual 
dysfunction due to depression (Ogbera et al., 2009). 
Also, depression is strongly associated with diabetes. 
There can be many reasons other than diabetes 
that causes depression which may include financial 
status, employment status, educational background 
and many more (Fugl-Meyer and Sjogren, 1999). 
Depression further worsen the complications of 
diabetes (Basson, 2005) which then affect quality 
of life,relationship status,  confidence, health and a 
woman’s self image which ultimately worsen sexual 
performance also although the exact mechanism of 
action of depression in diabetic female is not known.
Figure 1: Sexual Dysfunction overlay of pathogenesis in females with Diabetes.
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4. Diagnosis
In order to observe whether a diabetic woman has sexual 
dysfunction or not, her sexual and medical history, co-
morbid illness, her medication as well as woman’s current 
interpersonal and Psychosocial status, should be evaluated. 
The various diagnostic approaches include the following:
• The Female Sexual Function Index (FSFI): the 
FSFI is a brief questionnaire which measures 
sexual functioning in women. It is used to access 
domains like sexual arousal,satisfaction and 
orgasm. The FSFI may also be useful for evaluating 
the treatment outcome in clinical trials, but this 
remains to be demonstrated.
• The Brief Index of Sexual Functioning for Women 
(BISF-W): it refers to short, standardized self report 
which is used to examine the sexual functioning in 
women. It provides a comprehensive and reliable 
assessment to check the domains of sexual health 
in a number of women.
• Derogates Interview for Sexual Function (DISF/
DISF – SR): it is a brief semi-structured interview, 
which is designed for the degree estimates the 
quality of an individual’s sexual functioning in 
quantitative terms. It represents the degree of 
the phase of the sexual response cycle. It consists 
of five domains such as sexual arousal, sexual 
behaviour,sexual cognition, sexual drive and 
orgasm. It requires 15-20 minutes to access sexual 
functioning in women and men also.
• The Female Sexual Distress Scale (FSDS): It is used 
to assess sexually relatedpersonal distress among 
women. It is also useful to check the possibility of 
depression in women regarding sexual health.
Table 1: Comparison of scores in five sexual domains in diabetic and control women.
Sex drive Arousal Lubrication Orgasm Satisfaction
Patient 231 228 224 256 242
Control 153 152 152 151 137
P value(0.001) >0.001 >0.001 >0.001 >0.001 >0.001
Table 2: Effect of diabetes on women sexuality
Patient no Sexual desire Excitement Orgasm Dysparenuia
No.1 No effect 14%Difficulty in vaginal lubrication Anorgasmy in 36% 3% had Dysparenuia
No.2 No effect Sensibility affected  in 27% Absence of orgasm in 1% -
No.3 No effect - Absence of orgasm in 18% -
No.4 Decrease in 47% Sensibility affected in 47% Anorgasmy in 33%
No.5 Decrease in 20% In 24 % problem with arousal No difference 12 % had pain and discomfort 
No.6 Decrease in 24% Reduced vaginal lubrication in 18% Orgasmic dysfunction in 19% 10% had pain during coitus 
No.7 Significantly less desire Reduced vaginal lubrication in 45% No difference
No.8 Decrease in 21% Problems with lubrication in 18% Orgasmic dysfunction 15% 21% reported some genital pain
4.1 Data Methods
Recovery of studies depended on The MEDLINE,Cochrane 
Library and EMBASE (until June2012) utilizing the 
terms type 1 and type2 diabetes,insulin-subordinate and 
non-insulin-dependent diabetes, sexual dysfunction, 
ladies, restricting thesearch to human investigations. A 
manual inquiry wasalso performed on reference records 
from s,reviews, publications, and procedures of global 
congresses. 
At the point when consequences of one examination 
were accounted for in more productions, just the latest and 
finish information were considered. Choices on trials to 
incorporate were taken UN indiscriminately by the three 
authors.Disagreements were settled by discussion.Excluded 
trials were related to the purpose behind prohibition. 
Twenty-six examinations met the incorporation criteria, all 
distributed as full reports (Table 2).
4.2 Extraction of Data 
Information concerning Studies, patent characteristics and 
considering results were disconnected by the three creators 
and inconsistencies were settled by discourse. 
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In a few examinations there were more arms, as 
composite casistics could be part into littler casistics; in such 
cases, a similar report shows up twice or all the more regularly 
in figures. Suitable approach as indicated by the favoured 
revealing things for precise audits and meta-investigations 
(PRISMA) proclamation was clung to. Since considers were 
of observational nature, quality criteria for clinical trials were 
not connected.
4.3 Analysis of the Data 
Impact measures were (I) the distinction of recurrence of 
FSD in diabetic and control ladies; and (ii) the distinction 
of FSFI score in diabetic and in control ladies. Study 
results (Beck Depression Inventory [BDI] and FSFI) were 
communicated as SMD, with 95% certainty interims (CIs) 
evaluated by an arbitrary impacts show as indicated by 
DerSimonian and Laird . For sexual brokefrequency, study 
result was communicated as OR, with 95% CI, assessed by 
irregular impacts demonstrate as indicated by Der Simonian 
and Laird .Studies were assembled by gatherings of patients 
(type 1 diabetes, type 2 diabetes, any sort of diabetes), and 
furthermore as per preselected limits (age, premenopausal or 
postmenopausal state or either condition, span of diabetes, 
weight record [BMI], ceaseless diabetic difficulties). 
Heterogeneity was surveyed through Q and I2 insights for 
every examination, and potential sources of heterogeneity 
were talked about where suitable . A P esteem <0.05 was 
viewed as demonstrative of factually critical heterogeneity. 
In each figure, vertical line speaks to no distinction in 
gatherings (0 for SMD, 1 for OR); squares and level lines 
speak to the point gauges and 95% CI for every examination; 
precious stones speak to pooled impact measure, with focus 
speaking to point gauge and width speaking to 95% CI. At 
long last, a meta-relapse examination was performed  in view 
of consideration  incorporated into the meta-investigation, 
thinking about the accompanying free factors: 
age, BMI, size of study, BDI,term of infection, metabolic 
control (HbA1c); the needy variable was LogOR or LogSMD. 
Every single factual investigation was performed by STATA 
12 (Stata Corporation, College Station, TX, USA).
4.4 FSFI(Female Sexual Function Index) Score 
The FSFI survey created by Rosen et al., comprises of 19 
questions taking into account the multidimensional appraisal 
of female sexual capacities in connection to the time of the 
most recent a month. The file has been institutionalized 
and balanced (in numerous dialect adaptations, including 
Polish) to separating sexual dysfunctions in ladies matured 
18–70 as per the present orders and suggestions of 
logical affiliations. The survey has archived believability, 
affectability, unwavering quality, and inward consistency, 
and additionally strength and repeatability about perceiving 
issue of dyspareunia, sexual want, sexual excitement and 
climax. The inquiries introduced in the survey have been 
assembled into six spaces sexual desire, lubrication,sexual 
arousal, sexual satisfaction,orgasm and dyspareunia. The 
last outcomes are acquired independently for each of the 
subscales by summing up the basic focuses which are a piece 
of every one of the areas and contemplating the assigned 
coefficient; the outcomes are additionally gotten universally 
(worldwide evaluation). For the evaluation of the specific 
spaces, the point score which might be gotten ranges from 0 
to 6.0 for sexual excitement, grease, dyspareunia and climax; 
from 1.2 to 6.0 for sexual want.
4.4.1 International index of erectile function (IIEF)
IIEF is an exploration instrument for the examination of male 
sexual capacities. IIEF is a multidimensional instrument for 
5-review self-evaluation of the considerable number of spaces 
of male sexual capacities in connection to the time of the 
most recent a month. This list has gotten institutionalization 
for separating sexual dysfunctions in men (matured 19– 82) 
as per universal agreement, and it is authoritatively accessible 
in 32 dialect forms, including Polish. It is described by high 
validity, dependability, affectability, and repeatability in the 
discovery of changes, affirmed in more than 50 clinical trial. 
The utilization of the IIEF in the first or the abbreviated variant 
(IIEF-5) is a suggested standard in the acknowledgment 
and appraisal of the erectile broke seriousness review. IIEF 
poll incorporates 15 things gathered into 5 aggregate spaces 
(subscales) depicting: I—erection (6 questions); II—climax 
(2 questions); III—sexual want (2 questions); IV—sex 
fulfilment (3 inquiries); and V—general sexual fulfilment (2 
questions). An extra investigation of the subscale alluding to 
erection considers separating four conditions of seriousness 
of erection issue: absence of erection issue (26– 30 focuses); 
and gentle (17– 25 focuses),moderate(11–16 focuses), and 
severe(6–10 focuses) erection issue. An esteem equivalent 
to or lesser than 25 focuses (cut-off point) is consider as 
the event of clinically critical erectile issue. The Cronbach 
estimation of IIEF for our outcomes was assessed at the level 
of 0.930 for type 1 diabetes patients and 0.880 for controls, 
demonstrating high unwavering quality.
4.5 The Beck Depression Inventory (BDI)
The Beck Depression Inventory (BDI) is a 21-point screening 
tool use for assess the degree of Intensity of mood disorder 
symptoms (depression). The scale consists of 21 questions 
evaluated from 0 to 3 points. The results obtained in the 
BDI fluctuate in the range 0–63. A score below 10 points 
is considered as  normal. Severe depression is suggested by 
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a score within the range above 24, moderate depression 
by 16–23, andMild depression iswithin the range 10–15. 
BDI is a questionnaire standardized and validated for Polish 
conditions which has been numerously applied in studies 
assessing mood disorders; it possesses a high Cronbach 
reliability coefficient—0.92–0.93. The Cronbach _ value of 
BDI for our results was estimated at the level of 0.857 for 
men and 0.916 for women, showing high reliability.
5. Therapeutic Approaches
Currently, there is not any specific treatment available for 
female sexual dysfunction in diabetes mellitus. The most 
possible treatment of Female Sexual Dysfunction (FSD) 
would be related to, optimal diabetic control, psychotherapy 
and lifestyle changes. Recommendations from various health 
organizations suggested that adopting a healthy lifestyle 
and by treating depression can lower the incidence of FSD 
among females. A study by Giugliano et al., Found a positive 
correlation between one’s adherence to a Mediterranean diet 
and FSFI score in type 2 diabetic women. Women who were 
on the Mediterranean diet was found to have the lowest 
prevalence rate of sexual dysfunction and thereby improving 
their total FSFI score.
Moreover, maintaining a healthy lifestyle and achieving 
proper glycemic control may decrease the, endothelial 
dysfunction,insulin resistance and oxidative stress, resulting 
in a lower rate of sexual disorders. Furthermore, hormonal 
replacement therapy(HRT) in postmenopausal women 
has been approved by FDA to increase the vasodilatation 
by acting on NO mediated smooth muscle. Also, vaginal 
lubrication and vulvar engorgement can also be improved 
by inhibiting PDE5 receptors.
5.1 Some Additional Therapeutic Approach 
Additionally, sexual function can be improved by using 
adequate amounts of estrogens in hormone replacement 
therapy. The mechanism involved in its acts by inducing the 
proliferation of the superficial layer of the vaginal mucosa, 
which results in improved vaginal pH, increased vaginal 
blood flow to enhance the lubrication need for sexual 
intercourse and elasticity. However, there are also certain 
studies that have recognized the function of testosterone in 
female sexual desire, orgasm,arousal and genital sensation. 
Testosterone seems to improve the sexual function of 
women, but due to its masculinised side effects, its long term 
use is not recommended for treating FSD. Psychotherapy 
is another essential aspect that needs to be treated properly 
for better sexual functions as depression is found to be the 
major risk factor in diabetic patients. Cognitive-behavioral 
psychotherapy is the proposed management for disorders of 
desire or vaginismus. Additionally, couple therapy has also 
been great for partner intimacy.Women with orgasm or 
arousal disorders can benefit from the FDA approved Eros 
Clitoral therapy device. The device needs to place over the 
clitoris, which then produces a gentle vacuum that increases 
the blood flow to the female genital. This in turn enhances 
the sensitivity of genital of females. The Inters rim system is 
a method by which nerve get stimulated and was originally 
intended for the treatment of urine incontinence.  But it is 
now tested for arousal or orgasm disorders.
6. Discussion
An increased prevalence of  sexual  disorders has been 
reported in patients with  diabetes. The incidence 
of  sexual  dysfunction in patients with  diabetesrelated 
with the duration and age of  diabetes (Bąk et al., 2017). 
Female sexual dysfunction has been known to have many 
causes which include interpersonal, social, psychological 
and biological factors. According to recent research studies, 
there is a significant correlation found between BMI and 
abdominal circumference of sexual dysfunction. The 
number of sexual dysfunction is found to be more in obese 
women with diabetes as compared to normal women.
Theoretically, sexual functioning is also affected 
by diabetic neuropathy, but clinical studies are quite 
contradictory. A study by Abu Ali et al., Established a link 
of sexual dysfunction with that of retinopathy. Another 
study by B Erol et al., indicates the impairment in the 
somatic sensory system due to deterioration of genital and 
extragential sites in diabetic women. The study included 
the comparison of protogeometric values of genital sites in 
diabetic women with sexual impairment or without sexual 
impairment. Furthermore, the most affecting genital sites 
in the etiology of diabetes were found to be introits vagina 
and this site was found to have increased sensory threshold. 
Other affecting sites include the labiaminora,labia major, 
clitoris as well as vagina.
Besides this, Tyrer et al., Study on 82 insulin-dependent 
diabetic women evaluated the effects of diabetes on vaginal 
lubrication. The results show that inadequate vaginal 
lubrication is present in 10% of diabetic subjects compared 
with 2% in the control group. Moreover, Meeking et al., 
Studied sexual functioning in 161 diabetic subjects with both 
type 1 and type 2 DM. The study reported reducing sexual 
desire in nearly 64% of diabetic women. 70% of patients 
experienced loss of vaginal lubrication and 47% were having 
lesser sexual pleasure. Also, reduced vaginal sensation was 
found in 36% of patients. In a later study, it is evident from 
Schreiner-Engel et al., That diabetes had a negative impact 
on sexual desire, lubrication sexual satisfaction and orgasmic 
capacity in both females and males. The results were similar 
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to most of the researches done so far. One possible drawback 
of the study was with the patients treated with thyroid 
disease subclinicalhyperthyroid which may affect sexual 
function. However, if this was influencing the results, then 
it would show an even greater effect of diabetes on sexual 
health of both males and females. Doctors and pharmacists 
dealing with diabetic patients that they should be aware of 
possible presence of  sexual  dysfunction  in  femalepatients 
(Elyasi et al., 2015).
7. Conclusion
Diabetes mellitus is a leading public health concern across 
worldwide, which are growing at a faster rate affecting half of 
the population due to age, urbanization, physical inactivity, 
obesity, etc. Diabetes also affects the cardiovascular system, 
psychological and sexual dysfunction to a great extent. The 
prevalence rate of erectile dysfunction approaches to 50% 
among males, but the data for females are less conclusive 
due to a small sample size. There are many risk factors that 
are responsible for sexual impairment in females out of 
which psychological issues are considered to be as the main 
determinant of female sexual dysfunction. Depression plays 
a major role in the pathogenesis of FSD and interpersonal 
relationships and may result in poor quality of life.Recent 
studies indicate that diabetic women are at higher risk 
for developing sexual dysfunction as compared to women 
without diabetes. The adoption of a healthy lifestyle and 
exercise can help in preventing and treating these disorders 
and also lowering the burden of chronic diseases. However, 
depression can be treated with some antidepressants. By 
adopting all of these can help improve sexual activity and 
well being of an individual.
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